Correlation Between Kronos Bio and Unity Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kronos Bio and Unity Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kronos Bio and Unity Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kronos Bio and Unity Biotechnology, you can compare the effects of market volatilities on Kronos Bio and Unity Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kronos Bio with a short position of Unity Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kronos Bio and Unity Biotechnology.

Diversification Opportunities for Kronos Bio and Unity Biotechnology

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Kronos and Unity is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and Unity Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unity Biotechnology and Kronos Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kronos Bio are associated (or correlated) with Unity Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unity Biotechnology has no effect on the direction of Kronos Bio i.e., Kronos Bio and Unity Biotechnology go up and down completely randomly.

Pair Corralation between Kronos Bio and Unity Biotechnology

Given the investment horizon of 90 days Kronos Bio is expected to generate 0.97 times more return on investment than Unity Biotechnology. However, Kronos Bio is 1.03 times less risky than Unity Biotechnology. It trades about -0.01 of its potential returns per unit of risk. Unity Biotechnology is currently generating about -0.04 per unit of risk. If you would invest  234.00  in Kronos Bio on September 26, 2024 and sell it today you would lose (139.00) from holding Kronos Bio or give up 59.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kronos Bio  vs.  Unity Biotechnology

 Performance 
       Timeline  
Kronos Bio 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Kronos Bio are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Kronos Bio is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Unity Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Unity Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Kronos Bio and Unity Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kronos Bio and Unity Biotechnology

The main advantage of trading using opposite Kronos Bio and Unity Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kronos Bio position performs unexpectedly, Unity Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unity Biotechnology will offset losses from the drop in Unity Biotechnology's long position.
The idea behind Kronos Bio and Unity Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets